Skip to main content
. 2015 Nov 10;10(5):1081–1091. doi: 10.1038/ismej.2015.198

Figure 4.

Figure 4

Trends in the relative abundance of bacterial species with change in disease period. Parameters are extracted from mixed-effects models based on 237 samples from 12 patients. (B0) baseline pre-CFPE, (E) CFPE, 30 days prior to antibiotic treatment, (T) period of time patients were receiving treatment for pulmonary exacerbation, (R) recovery, 30 days post-treatment, (B1) baseline post-CFPE. **P<0.001, *P<0.05. indicates rare group membership.